NCT03960463View on ClinicalTrials.gov

EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

December 15, 2023

Study Completion Date

July 24, 2024

Conditions
Surgical WoundDiabetesAmputation WoundIncision WoundPeripheral Arterial DiseaseBreast CancerDiabetic Foot
Interventions
DEVICE

Transcu O2®

Participants randomized into study active group will be provided with a Transcu O2® at their surgical site and followed for 4 weeks.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

Electrochemical Oxygen Concepts, Inc.

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT03960463 - EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds | Biotech Hunter | Biotech Hunter